Wave Life Sciences (NASDAQ:WVE) Earns Buy Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a report published on Wednesday morning,Benzinga reports. They currently have a $22.00 price objective on the stock. HC Wainwright also issued estimates for Wave Life Sciences’ Q1 2025 earnings at ($0.26) EPS, Q2 2025 earnings at ($0.24) EPS, […]
